374 A first-in-human Phase 1/2 open label trial evaluating the safety, pharmacology, and preliminary efficacy of VT1021 in subjects with advanced solid tumors
Main Authors: | Afshin Dowlati, Andrea Bullock, Susanna Ulahannan, Manish Patel, Shubham Pant, Amita Patnaik, Marsha Crochiere, Devalingam Mahalingam, Wael Harb, Haider Mahdi, Manmeet Ahluwalia, Patrick Wen, Mary Mulcahy, Robert Guttendorf, Lou Vaickus, Suming Wang, Melanie Vincent, Michael Cieslewicz, Jing Watnick |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2020-11-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Similar Items
-
First-in-human phase I dose escalation trial of the first-in-class tumor microenvironment modulator VT1021 in advanced solid tumors
by: Devalingam Mahalingam, et al.
Published: (2024-01-01) -
VT /
by: Hilal Asyraf, 1989- 231779
Published: (2009) -
Petrology of Monadnock Mt., Vt.
by: Vagt, William Arthur
Published: (2010) -
ISOLATION OF VT1 AND/OR VT2 GENE-BEARING Escherichia coif FROM CATTLE, SWINE AND SHEEP AND GOAT = ISOLASI Escherichia coli PEMBAWA GEN VT1 DAN VT2 DART SAPI, BABI DAN DOMBA/KAMBING
by: Drastini, Yatri, et al.
Published: (2002) -
ISOLATION OF VT1 AND/OR VT2 GENE-BEARING Escherichia coif FROM CATTLE, SWINE AND SHEEP AND GOAT = ISOLASI Escherichia coli PEMBAWA GEN VT1 DAN VT2 DART SAPI, BABI DAN DOMBA/KAMBING
by: Perpustakaan UGM, i-lib
Published: (2002)